
Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

Editor of Patient Care Online.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

A new review of >60 000 patients with diabetes found CGM use during the early weeks of the COVID-19 pandemic improved their time in range.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

New research suggests obesity is responsible for 30%-53% of new type 2 diabetes cases in the US annually.

Global confirmed cases of COVID-19 have surpassed 109 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

Global confirmed cases of COVID-19 have surpassed 108 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

Double-masking found to reduce SARS-CoV-2 spread, FDA decision on antibody cocktail for treatment of COVID-19, and 8 more news briefs summarized for primary care.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

In the first study of its kind, pre-existing eosinophilia was protective from COVID-19-related hospital admission and mortality in patients with asthma.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

The FDA issued an EUA to Eli Lilly and Company for bamlanivimab and etesevimab administered together for the treatment of mild-to-moderate COVID-19.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

Global confirmed cases of COVID-19 have surpassed 106 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

The submission is based on data from the phase 3 ENSEMBLE clinical trial that showed the investigational single-dose vaccine met all primary and key secondary endpoints.

Global confirmed cases of COVID-19 have surpassed 105 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

A new primary analysis found that the AstraZeneca and University of Oxford COVID-19 vaccine is safe and effective at preventing infection and reducing transmission.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

Global confirmed cases of COVID-19 have surpassed 103 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

Will desire to return to “normal” life propel patients to get a COVID-19 vaccine? What do they think about efforts to contain transmission? Answers and more insights here.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

US levels of SARS-CoV-2 circulation, associated illnesses, and deaths have been decreasing, but rising reporting delays due to holidays warrant caution.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

In episode 6 of Primary Viewpoints, physician mental health expert Michael Myers, MD, discusses the state of physician mental health during the COVID-19 pandemic.

Global confirmed cases of COVID-19 have surpassed 100 million. We summarize more of today's data from the Johns Hopkins COVID-19 interactive map.

Compared to medication and lifestyle changes, metabolic surgery is more effective in the long-term control of severe T2D, a new study found.

Data from the Johns Hopkins COVID-19 interactive map on coronavirus cases, mortalities, recoveries, and more.

Merck announced today that it will halt development of its COVID-19 vaccine candidates, citing inadequate immune responses to the vaccines.